Assessing a Patient With Long COVID-19
April 10, 2021
April 10, 2022
Scroll to the Bottom of this Information to Begin this Course
This activity is provided by The France Foundation.
This activity is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
- Physicians — maximum of 0.50 AMA PRA Category 1 Credit(s)™
All other healthcare professionals completing this course will be issued a statement of participation.
This activity is intended for pulmonologists and other members of the interdisciplinary healthcare team involved in the care of patients with and recovering from COVID-19.
This activity will cover the assessment of patients with symptoms of long-COVID.
Upon completion of this activity, participants should be better able to:
- Describe COVID-19 induced acute lung injury and ARDS
- Discuss the potential progression of COVID-19 effects on the lungs
- Discuss emerging clinical information regarding COVID-19 and chronic lung disease such as ILD
- Review long-term management strategies for these patients
Jennifer Possick, MD
Medical Director for Winchester Chest Clinic
Yale University School of Medicine
The France Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The France Foundation designates this enduring activity for a maximum of 0.50 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
Disclosures of Conflicts of Interest
In accordance with the ACCME Standards for Commercial Support, The France Foundation (TFF) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TFF resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs. Furthermore, TFF seeks to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. TFF is committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of a commercial interest.
Activity Staff Disclosures
Patrick Harty, PhD, has disclosed that his spouse is employed by Pfizer, Inc, and they hold stock in Pfizer, Inc. All other planners, reviewers, editors, staff, CME committee, or other members at The France Foundation who control content have no relevant financial relationships to disclose.
Faculty DisclosuresContent Creators
The faculty listed below report that they have no relevant financial relationships to disclose:
- Dr. Jennifer Possick
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures.
- Participate in the online activity.
- Submit the evaluation form.
Certificates will be emailed to the participant.
Course Viewing Requirements
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
The France Foundation (TFF) requires CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental, and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. TFF does not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.
The France Foundation presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation and the commercial supporter(s) assume no liability for the information herein.
For CME questions please contact: firstname.lastname@example.org.